Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ANDRX (ADRX) -- Ignore unavailable to you. Want to Upgrade?

To: Jolie Renee who wrote (71)	4/26/1998 6:12:00 PM
From: Rich1	Read Replies (1) \| Respond to of 127

I am unable to pull the story off the IBD Website. Story talks about the time release forms of best selling drugs ADRX sells. Good comments from Warburg Dillon analyst. Company has a joint venture with Watson Pharmaceuticals which holds an 18% interest in ADRX. Company expects to report ist quarter results on Monday. The company hopes to establish an international presence by year end. Expects to turn its first profits this year.